{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:33:09Z","timestamp":1777059189222,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471597"],"award-info":[{"award-number":["81471597"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671612"],"award-info":[{"award-number":["81671612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601427"],"award-info":[{"award-number":["81601427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2014A030313074"],"award-info":[{"award-number":["2014A030313074"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313576"],"award-info":[{"award-number":["2017A030313576"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2016A030313307"],"award-info":[{"award-number":["2016A030313307"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Medical Scientific Research Foundation","award":["A2017109"],"award-info":[{"award-number":["A2017109"]}]},{"name":"Key Program of Young Teachers Foundation of Sun Yat-sen University","award":["17ykjc12"],"award-info":[{"award-number":["17ykjc12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1548-5","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T08:50:16Z","timestamp":1525251016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study"],"prefix":"10.1186","volume":"20","author":[{"given":"Yu-Lan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Zi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Qian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Da","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"issue":"23","key":"1548_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"issue":"4","key":"1548_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1099\/0022-1317-49-4-305","volume":"49","author":"A Ebringer","year":"2000","unstructured":"Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity. J Med Microbiol. 2000;49(4):305\u201311.","journal-title":"J Med Microbiol"},{"issue":"8","key":"1548_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895\u2013905.","journal-title":"Nat Med"},{"issue":"10003","key":"1548_CR4","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355.","journal-title":"Lancet"},{"issue":"10","key":"1548_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.revmed.2010.08.013","volume":"32","author":"B Terrier","year":"2011","unstructured":"Terrier B, Cacoub P. Hepatitis B virus, extrahepatic immunologic manifestations and risk of viral reactivation. Rev Med Interne. 2011;32(10):622\u20137.","journal-title":"Rev Med Interne"},{"key":"1548_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/j.1572-0241.2005.41308.x","volume":"100","author":"A Mason","year":"2005","unstructured":"Mason A, Theal J, Bain V, Adams E, Perrillo R. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am J Gastroenterol. 2005;100:972\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1548_CR7","first-page":"111","volume":"24","author":"S Momohara","year":"2006","unstructured":"Momohara S, Okamoto H, Tokita N, Tomatsu T, Kamatani N. Rapidly destructive knee arthropathy associated with hepatitis B. Clinical &amp. Exp Rheumatol. 2006;24:111\u20132.","journal-title":"Exp Rheumatol"},{"issue":"4","key":"1548_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0002-9343(74)90020-5","volume":"57","author":"HR Schumacher","year":"1974","unstructured":"Schumacher HR, Gall EP. Arthritis in acute hepatitis and chronic active hepatitis. Pathology of the synovial membrane with evidence for the presence of Australia antigen in synovial membranes. Am J Med. 1974;57(4):655\u201364.","journal-title":"Am J Med"},{"issue":"1","key":"1548_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1529-0131(200001)43:1<232::AID-ANR28>3.0.CO;2-O","volume":"43","author":"A Csepregi","year":"2000","unstructured":"Csepregi A, Rojkovich B, Nemesanszky E, Poor G, Hejjas M, Horanyi M. Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: a sequel of virus persistence. Arthritis Rheum. 2000;43(1):232\u20133.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1548_CR10","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/BF01299871","volume":"37","author":"LJ Scully","year":"1992","unstructured":"Scully LJ, Karayiannis P, Thomas HC. Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis. Dig Dis Sci. 1992;37(11):1757\u201360.","journal-title":"Dig Dis Sci"},{"issue":"18","key":"1548_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003551","volume":"95","author":"C Hsu","year":"2016","unstructured":"Hsu C, Lang H, Huang K, Lin HH, Chen C. Association of rheumatoid arthritis and hepatitis B infection. Medicine. 2016;95(18):e3551.","journal-title":"Medicine"},{"issue":"3","key":"1548_CR12","first-page":"474","volume":"28","author":"A Csepregi","year":"2001","unstructured":"Csepregi A, Nemesanszky E, Rojkovich B, Poor G. Rheumatoid arthritis and hepatitis B virus: evaluating the pathogenic link. J Rheumatol. 2001;28(3):474\u20137.","journal-title":"J Rheumatol"},{"issue":"6","key":"1548_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10067-013-2170-1","volume":"32","author":"C Zou","year":"2013","unstructured":"Zou C, Zhu L, Li Y, Mo Y, Zheng D, Ma J, et al. The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis. Clin Rheumatol. 2013;32(6):787\u201395.","journal-title":"Clin Rheumatol"},{"key":"1548_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/1471-2474-15-449","volume":"15","author":"YQ Mo","year":"2014","unstructured":"Mo YQ, Liang AQ, Ma JD, Chen LF, Zheng DH, Schumacher HR, et al. Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice. BMC Musculoskelet Disord. 2014;15:449.","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"1548_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1548_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CR, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1548_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13075-015-0803-2","volume":"17","author":"J Ma","year":"2015","unstructured":"Ma J, Wei X, Zheng D, Mo Y, Chen L, Zhang X, et al. Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther. 2015;17:289.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1548_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69(6):964\u201375.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1548_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492\u2013509.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1548_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762\u201384.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1548_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64(5):625\u201339.","journal-title":"Arthritis Care Res"},{"issue":"5","key":"1548_CR22","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 2012;64(5):640\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1548_CR23","doi-asserted-by":"publisher","first-page":"179284","DOI":"10.1155\/2014\/179284","volume":"2014","author":"JD Ma","year":"2014","unstructured":"Ma JD, Zhou JJ, Zheng DH, Chen LF, Mo YQ, Wei XN, et al. Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis. Mediators Inflamm. 2014;2014:179284.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"1548_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/annrheumdis-2012-202779","volume":"72","author":"D van der Heijde","year":"2013","unstructured":"van der Heijde D, van der Helm-van MA, Aletaha D, Bingham CO, Burmester GR, Dougados M, et al. EULAR definition of erosive disease in light of the 2010 ACR\/EULAR rheumatoid arthritis classification criteria. Ann Rheum Dis. 2013;72(4):479\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1548_CR25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/annrheumdis-2012-202433","volume":"73","author":"T Takeuchi","year":"2014","unstructured":"Takeuchi T, Yamanaka H, Ishiguro N, Miyasaka N, Mukai M, Matsubara T, et al. Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study. Ann Rheum Dis. 2014;73(3):536\u201343.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1548_CR26","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/rheumatology\/kep155","volume":"48","author":"N Vastesaeger","year":"2009","unstructured":"Vastesaeger N, Xu S, Aletaha D, St CE, Smolen JS. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology (Oxford). 2009;48(9):1114\u201321.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1548_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van\u2019t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39(1):34\u201340.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 4","key":"1548_CR28","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.1093\/cid\/ciw043","volume":"62","author":"SA Gonzalez","year":"2016","unstructured":"Gonzalez SA, Perrillo RP. Hepatitis B Virus Reactivation in the setting of cancer chemotherapy and other immunosuppressive drug therapy. Clin Infect Dis. 2016;62(Suppl 4):S306\u201313.","journal-title":"Clin Infect Dis"},{"key":"1548_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrrheum.2012.63","volume":"8","author":"D Vassilopoulos","year":"2012","unstructured":"Vassilopoulos D, Calabrese LH. Management of rheumatic disease with comorbid HBV or HCV infection. Nat Rev Rheumatol. 2012;8:348\u201357.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1548_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.10.038","volume":"148","author":"RP Perrillo","year":"2015","unstructured":"Perrillo RP, Gish R, Falck-Ytter YT. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148(1):221\u201344.","journal-title":"Gastroenterology"},{"issue":"1","key":"1548_CR31","first-page":"3","volume":"92","author":"RA Willson","year":"1997","unstructured":"Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol. 1997;92(1):3\u201317.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1548_CR32","first-page":"1250","volume":"17","author":"E Hachulla","year":"1990","unstructured":"Hachulla E, Houvenagel E, Mingui A, Vincent G, Laine A. Reactive arthritis after hepatitis B vaccination. J Rheumatol. 1990;17(9):1250\u20131.","journal-title":"J Rheumatol"},{"issue":"10","key":"1548_CR33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/rheumatology\/38.10.978","volume":"38","author":"JF Maillefert","year":"1999","unstructured":"Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford). 1999;38(10):978\u201383.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1548_CR34","first-page":"1687","volume":"25","author":"JE Pope","year":"1998","unstructured":"Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol. 1998;25(9):1687\u201393.","journal-title":"J Rheumatol"},{"key":"1548_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/rheumatology\/33.10.991-a","volume":"33","author":"G Vautier","year":"1994","unstructured":"Vautier G. Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. Br J Rheumatol. 1994;33:991.","journal-title":"Br J Rheumatol"},{"issue":"4","key":"1548_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/annrheumdis-2011-200108","volume":"71","author":"Y Urata","year":"2012","unstructured":"Urata Y, Uesato R, Tanaka D, Nakamura Y, Motomura S. Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study. Ann Rheum Dis. 2012;71(4):534\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1548_CR37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jhep.2004.11.031","volume":"42","author":"FL Yu","year":"2005","unstructured":"Yu FL, Liu HJ, Lee JW, Liao MH, Shih WL. Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. J Hepatol. 2005;42(4):520\u20137.","journal-title":"J Hepatol"},{"issue":"4","key":"1548_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0149-2918(04)90048-3","volume":"26","author":"EK Li","year":"2004","unstructured":"Li EK, Tam LS, Tomlinson B. Leflunomide in the treatment of rheumatoid arthritis. Clin Ther. 2004;26(4):447\u201359.","journal-title":"Clin Ther"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1548-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:24:28Z","timestamp":1556738668000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1548-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1548-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in compliance with the Helsinki Declaration. Due to the retrospective nature of the study, informed consent was waived. The study was approved by the Medical Ethics Committee of Sun Yat-Sen Memorial Hospital (identifier SYSEC-KY-KS-011).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have approved publication of the data in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"81"}}